GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioDelivery Sciences International Inc (FRA:BD5) » Definitions » Cyclically Adjusted Price-to-FCF

BioDelivery Sciences International (FRA:BD5) Cyclically Adjusted Price-to-FCF : (As of May. 28, 2024)


View and export this data going back to 2004. Start your Free Trial

What is BioDelivery Sciences International Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


BioDelivery Sciences International Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for BioDelivery Sciences International's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioDelivery Sciences International Cyclically Adjusted Price-to-FCF Chart

BioDelivery Sciences International Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BioDelivery Sciences International Quarterly Data
Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BioDelivery Sciences International's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, BioDelivery Sciences International's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioDelivery Sciences International's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioDelivery Sciences International's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where BioDelivery Sciences International's Cyclically Adjusted Price-to-FCF falls into.



BioDelivery Sciences International Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

BioDelivery Sciences International's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2021 is calculated as:

For example, BioDelivery Sciences International's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2021 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2021 (Change)*Current CPI (Dec. 2021)
=0.118/117.6295*117.6295
=0.118

Current CPI (Dec. 2021) = 117.6295.

BioDelivery Sciences International Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201203 0.548 96.783 0.666
201206 0.267 96.819 0.324
201209 -0.343 97.633 -0.413
201212 -0.170 96.871 -0.206
201303 -0.278 98.209 -0.333
201306 -0.244 98.518 -0.291
201309 -0.377 98.790 -0.449
201312 -0.290 98.326 -0.347
201403 -0.004 99.695 -0.005
201406 -0.145 100.560 -0.170
201409 -0.041 100.428 -0.048
201412 -0.286 99.070 -0.340
201503 -0.092 99.621 -0.109
201506 -0.251 100.684 -0.293
201509 -0.227 100.392 -0.266
201512 0.504 99.792 0.594
201603 -0.290 100.470 -0.340
201606 -0.198 101.688 -0.229
201609 -0.213 101.861 -0.246
201612 -0.223 101.863 -0.258
201703 -0.152 102.862 -0.174
201706 -0.124 103.349 -0.141
201709 -0.063 104.136 -0.071
201712 -0.172 104.011 -0.195
201803 -0.123 105.290 -0.137
201806 -0.044 106.317 -0.049
201809 -0.087 106.507 -0.096
201812 -0.072 105.998 -0.080
201903 -0.037 107.251 -0.041
201906 -0.016 108.070 -0.017
201909 -0.013 108.329 -0.014
201912 0.173 108.420 0.188
202003 0.054 108.902 0.058
202006 -0.011 108.767 -0.012
202009 0.072 109.815 0.077
202012 0.086 109.897 0.092
202103 0.086 111.754 0.091
202106 0.074 114.631 0.076
202109 0.058 115.734 0.059
202112 0.118 117.630 0.118

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BioDelivery Sciences International  (FRA:BD5) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


BioDelivery Sciences International Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of BioDelivery Sciences International's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


BioDelivery Sciences International (FRA:BD5) Business Description

Traded in Other Exchanges
N/A
Address
4131 ParkLake Avenue, Suite 225, Raleigh, NC, USA, 27612
BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.

BioDelivery Sciences International (FRA:BD5) Headlines

No Headlines